FBC advises Monsanto in investment in Evogene and acquisitions of Rosetta Green and the Beelogics group of companies

By Hagar Keren-Hackim & Amit Dat & Itiel Ben-Haim & Ronald Lehmann & Raz Tepper & Ron Sitton | Feb 2013 | Transaction

FBC advises Monsanto, in an investment in Evogene, a publicly traded Israeli company that develops genetic engineering technology, in its acquisition of Rosetta Green, a public Israeli company, and the Beelogics group of companies.